PHI with Diffuse periaxial encephalitis
How does this condition affect your private health insurance?
Encephalitis periaxialis diffusa, or Schilder's disease, is a rare and severe demyelinating disorder affecting primarily children and young adults. It involves large, often symmetrical, demyelinated lesions within the cerebral white matter, distinct from multiple sclerosis in its lesion size and distribution. Patients typically experience progressive neurological deficits including visual and auditory impairment, spasticity, seizures, cognitive decline, and speech disturbances. The disease course is usually aggressive, leading to profound disability and often premature death. Its exact cause is largely unknown, and treatment focuses on supportive care and symptom management due to the lack of specific curative therapies.
PKV Risk Assessment
Individual, specialized PHI providers may still insure you, but with a significant surcharge.
Impact on Your Insurance Policy
Duration of Illness (Initial)
Acute to subacute onset, evolving over weeks to several months.
Duration of Illness (Lifetime)
Chronic and progressive, typically leading to severe disability and often premature death within months to a few years.
Cost of Treatment (Initial)
High, involving extensive diagnostics (MRI, CSF analysis), hospitalization, and initiation of symptomatic and supportive therapies.
Cost of Treatment (Lifetime)
Very high, encompassing long-term specialized medical care, rehabilitation, assistive devices, continuous medication, and palliative care.
Mortality Rate
High, often within a few years of diagnosis due to the progressive nature of the disease and severe neurological damage.
Risk of Secondary Damages
Very high, including severe neurological deficits (motor, cognitive, sensory), permanent vision/hearing loss, epilepsy, and vegetative states.
Probability of Full Recovery
Extremely low; significant and often irreversible neurological deficits are almost always present, and the disease is typically progressive.
Underlying Disease Risk
Low for direct underlying genetic causes in most cases, but differential diagnosis includes other demyelinating diseases or leukodystrophies.